本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ocular Therapeutix

11.33
-0.0500-0.44%
盤後11.330.00000.00%17:20 EDT
成交量:212.59萬
成交額:2,416.32萬
市值:18.05億
市盈率:-9.85
高:11.57
開:11.56
低:11.23
收:11.38
資料載入中...
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/07/22

重要事件披露

8-K - Current report
2021/06/22

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report
2021/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans